FMR LLC 13D and 13G filings for Regulus Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-04-10 10:06 am Unchanged | 2024-04-09 | 13G | Regulus Therapeutics Inc. RGLS | FMR LLC | 2,922,600 4.464% | 0 (Unchanged) | Filing |
| 2024-02-09 09:49 am Purchase | 2024-02-08 | 13G | Regulus Therapeutics Inc. RGLS | FMR LLC | 2,922,600 14.452% | 727,600 (+33.15%) | Filing |
| 2022-10-11 09:03 am Purchase | 2022-10-07 | 13G | Regulus Therapeutics Inc. RGLS | FMR LLC | 2,195,000 14.998% | 2,195,000 (New Position) | Filing |